A systematic review in the August 22/29 issue of the Journal of the American Medical Association provides an overview of primary and secondary interventions for diabetic retinopathy (DR).
Read More »Diabetes In Control
Depression Care Management Can Reduce Mortality in Older Patients With Diabetes
Depression care management may reduce 5-year mortality in older primary care patients with both depression and diabetes, according to the results of a new study,
Read More »Diabetes Can Impair Tuberculosis Treatment Response
Patients with tuberculosis and diabetes do not respond as well to tuberculosis therapy as those who are non-diabetic, Dutch researchers report.
Read More »Whole Grains Protect Against Diabetes
Whole grains may help prevent type 2 diabetes, with consistent results across studies, researchers said.
Read More »Discovery Paves Way for a New Class of Diabetes Drugs
A multidisciplinary team led by researchers at the University of California, San Diego has determined the structure of a protein found in cells that shows potential as a target for the development of new drugs to treat diabetes.
Read More »Brain Link Seen in Type 2 Diabetes
Glucose Problems in Certain Brain Cells May Be a Red Flag of Type 2 Diabetes Risk
Read More »Obesity Rates Predicted by Property Values and Zip Codes
For each additional $100,000 in the median price of homes, researchers found, obesity rates in a given ZIP code dropped by 2 percent.
Read More »Anodyne Therapy Peer-Reviewed Study Demonstrates
Anodyne Therapy Peer-Reviewed Study Demonstrates Reduction in Pain and Pain Medication Use
Read More »Long-Acting Insulin Glargine Significantly Lowers Free Fatty Acids
The long-acting insulin glargine has lipid-lowering effects that investigators believe are independent of its effect on blood sugar, according to results of two trials presented at the 67th Scientific Sessions of the American Diabetes Association in Chicago.
Read More »Diabetics Face Higher 30-Day and 1-Year Mortality After Unstable Angina
Diabetics with unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) or STEMI face a much higher risk of mortality within one year of their acute coronary syndrome (ACS) event than nondiabetics, a new analysis shows.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.